GreatPoint Ventures

Founded 2015
Founders Andrew Perlman Ray Lane


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 61
Average round size
The average size of a deal this fund participated in
Portfolio companies 43
Rounds per year 10.17
Lead investments 8
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 5
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Software
  • Analytics
  • Machine Learning
  • Artificial Intelligence

GreatPoint Ventures appeared to be the VC, which was created in 2015.

The higher amount of exits for fund were in 2019. The average startup value when the investment from GreatPoint Ventures is more than 1 billion dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2019. Speaking about the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this GreatPoint Ventures performs on 23 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year.

The fund was created by Andrew Perlman, Ray Lane. The overall number of key employees were 5.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the GreatPoint Ventures, startups are often financed by Khosla Ventures, Globespan Capital Partners, Tim Disney. The meaningful sponsors for the fund in investment in the same round are Tao Capital Partners, Khosla Ventures, DNS Capital. In the next rounds fund is usually obtained by Khosla Ventures, Third Rock Ventures, Globespan Capital Partners.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Machine Learning, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Uptake, Beyond Meat, Even Financial. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Life By Spot

Life Insurance
$15M28 Jul 2021 Austin, Texas, United States


Health Care
Information Technology
$58M10 Jun 2021 San Francisco, California, United States


$20M01 Jun 2021 Austin, Texas, United States


Developer APIs
$260M18 May 2021 San Francisco, California, United States


Health Care
Health Insurance
$35M05 May 2021 San Francisco, California, United States

Cloud Data Services
Productivity Tools
Public Safety
$29M29 Apr 2021 Austin, Texas, United States

Spring Labs

Financial Services
$30M21 Apr 2021 Los Angeles, California, United States


Delivery Service
Health Care
Medical Device
$23M30 Mar 2021 San Francisco, California, United States

15 Mar 2021 San Francisco, California, United States
Spot Raises $17.5M in Funding

– Spot is an Austin, TX-based tech startup providing digital, on-demand injury insurance.
– The company raised $17.5m in funding.
– The round was led by GreatPoint Ventures, with participation from Montage Ventures, Mutual of Omaha, MS&AD, and Silverton Partners.
– The new capital will be used to grow the team, forge new partnerships, and ramp up marketing efforts.

Transcarent Raises $58 Million in Series B Funding to Accelerate Consumer-Directed Health and Care Experience for Self-Insured Employers

– Transcarent, a new and different consumer-directed health and care experience for employees of self-insured employers and their families, announced a $58m Series B investment led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners.
– This round brings Transcarent’s total funding to $98m and will allow the company to respond to the demand for rapid expansion of its innovative risk-based offering for self-insured employers.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GreatPoint Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: